CABOTEGRAVIR PPK SIMULATION TO INFORM Q2M STRATEGIES FOLLOWING DOSING INTERRUPTIONS
Cabotegravir (CAB) is an integrase strand transfer inhibitor formulated as long-acting (LA) injection for treatment and prevention of HIV, and as tablet for oral lead-in and bridging therapy for LA dose interruptions. CAB LA administered with rilpivirine (RPV) LA is a 2-drug regimen for HIV treatment with proven efficacy following LA injections monthly and every…